制吐療法の過去：『抗がん剤は怖い』はここから始まった、見えてきたアンメットニーズ・患者さんの視点〈特別企画 WJOGが初学者に教える制吐療法 ①〉

武田真幸

1896

全身性エリテマトーデスにおける骨壊死の予測因子前向きコホート研究～ホプキンスループスコホート32年の蓄積より～

Shun

1172

抄読会: SLEにおける皮膚生検の有用性

Shun

831

アクショナブルな遺伝子変異を有する非扁平上皮非小細胞肺癌に対するCGPの有用性の検討

日本臨床腫瘍学会

558

膠原病内科抄読会:SLEにおけるClinical Inertia （臨床的惰性）に関連する因子とアウトカム

Shun

名古屋市立大学

2026/8/22

概要

全身性エリテマトーデスにおけるClinical Inertiaが患者に与える影響について後方視的に観察した研究を記した論文を抄読会で扱いました.

Miyake H, Kida T, Yoshimi R, Michizu Y, Nishimura K, Sada KE, et al. Factors and outcomes related to clinical inertia in systemic lupus erythematosus: a multicentre LUNA cohort study. Rheumatology (Oxford). 2026 Jan 8;65(1):keaf504. PMID: 40981511.

本スライドの対象者

専攻医／専門医

参考文献

Miyake H, Kida T, Yoshimi R, Michizu Y, Nishimura K, Sada KE, et al. Factors and outcomes related to clinical inertia in systemic lupus erythematosus: a multicentre LUNA cohort study. Rheumatology (Oxford). 2026 Jan 8;65(1):keaf504. PMID: 40981511.
Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, et al. Clinical inertia. Ann Intern Med. 2001 Nov 6;135(9):825-34. PMID: 11694107.
https://showa-u-rheum.com/research-facility/ 2026/07/21 閲覧
Doria A, Gatto M, Zen M, Iaccarino L, Punzi L. Optimizing outcome in SLE: treating-to-target and definition of treatment goals. Autoimmun Rev. 2014 Jul;13(7):770-7. PMID: 24480071
Wolf MH, Putnam SM, James SA, Stiles WB. The Medical Interview Satisfaction Scale: development of a scale to measure patient perceptions of physician behavior. J Behav Med. 1978 Dec;1(4):391-401. PMID: 755868.
McElhone K, Abbott J, Shelmerdine J, Bruce IN, Ahmad Y,Teh LS et al. Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis Rheum. 2007 Aug 15;57(6):972-9. PMID: 17665467.
NCSS, LLC. Zero-inflated Poisson regression [software documentation]. Chapter 329. NCSS, LLC; 2023. Accessed July 26, 2026.
Kandane-Rathnayake R, Milea D, Louthrenoo W, Hoi A, Golder V, Cho J, et al. Longitudinal associations of flare and damage accrual in patients with systemic lupus erythematosus. Lupus Sci Med. 2025 Jan 19;12(1):e001363. PMID: 39832908;
磯谷俊太郎．抄読会：全身性エリテマトーデス患者における再発と損傷の長期的な関連［Internet］．Antaa Slide；2026 Jun 19［cited 2026 Jul 26］．Available from: https://slide.antaa.jp/article/view/0228617a70cd4ba9
磯谷俊太郎．臨床研究におけるSLE評価方法［Internet］．Antaa Slide；2023年4月13日［2026年7月26日閲覧］．
Jackman S. pscl: Classes and Methods for R Developed in the Political Science Computational Laboratory [computer software]. Version 1.5.9. Sydney: University of Sydney; 2024. doi:10.32614/CRAN.package.pscl.
Guzikevits M, Gordon-Hecker T, Rekhtman D, Salameh S, Israel S, Shayo M, et al. Sex bias in pain management decisions. Proc Natl Acad Sci U S A. 2024 Aug 13;121(33):e2401331121. PMID: 39102546.
Blumenstein I, Herrmann E, Filmann N, Zosel C, Tacke W, Bock H, et al. Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study. J Crohns Colitis. 2011 Jun;5(3):203-10PMID: 21575882.
Lesuis N, Befrits R, Nyberg F, van Vollenhoven RF. Gender and the treatment of immune-mediated chronic inflammatory diseases: rheumatoid arthritis, inflammatory bowel disease and psoriasis: an observational study. BMC Med. 2012 Aug 1;10:82. PMID: 22853635.